News & Updates

Show Multimedia Only
BP-lowering drugs reduce death in older hypertensive COVID-19 patients

BP-lowering drugs reduce death in older hypertensive COVID-19 patients

29 Mar 2022

Antecedent use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) among older COVID-19 patients with hypertension results in fewer all-cause deaths, whether in-hospital or shortly after discharge, compared with no antecedent use of renin-angiotensin system inhibitors (RASIs), a study has shown.

29 Mar 2022
Empagliflozin lowers mortality, cardiorenal events even in COPD presence Empagliflozin lowers mortality, cardiorenal events even in COPD presence

Empagliflozin lowers mortality, cardiorenal events even in COPD presence

28 Mar 2022 byJairia Dela Cruz

Among patients with type 2 diabetes mellitus and cardiovascular disease, those with concomitant chronic obstructive pulmonary disease (COPD) are at higher risk of mortality and adverse cardiorenal outcomes, including heart failure, according to post hoc analyses of the EMPA-REG OUTCOME trial. However, these outcomes can be prevented with empagliflozin treatment, regardless of the presence of COPD.

28 Mar 2022
Light drinking may protect against death after myocardial infarction

Light drinking may protect against death after myocardial infarction

24 Mar 2022 byStephen Padilla

Following an episode of myocardial infarction (MI), patients with light or moderate alcohol consumption appear to have a lower risk of mortality than nondrinkers, according to a study.

24 Mar 2022